Our initial criteria for peptides selection had been (1) the number of phage clones selected by phage library screen (Fig 1D), (2) binding affinity to ANXA1 (Fig 2C and 2D), and (3) in vivo tumor targeting activity (Fig 4). This evidence concerns the gene ANXA1 and neoplasm.